A world-renowned expert in tropical medicine and vector-borne diseases, Professor Hemingway brings over four decades of groundbreaking research, leadership, and strategic vision in global public ...

Received 3 Rare Pediatric Disease Designations (RPDD) from FDA for each of 3 potential therapies for 3 different rare inherited retinopathies ...

High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one <a target=_blank href= ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

A 36-year-old man from Jorabagan died from dengue virus at RG Kar Medical College Hospital, marking the first dengue death in ...

UD insect ecology and conservation student Thor Freeman pursues medical entomology career with the U.S. Air Force ...

Since its inception, 10 Institut Pasteur scientists have been awarded the Nobel Prize for Medicine, including two in 2008 for ... diseases in antimicrobial resistance, respiratory and vector-borne ...

As the heavy rainfall continues to batter several districts of Tamil Nadu, the State Health Department has issued a public ...

Scientists have successfully immortalized lip cells, creating a clinically relevant lab model that enables testing of new ...

As previously announced, IMUNON plans to hold an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in person to discuss the design for a Phase 3 pivotal study of IMNN-001 in ...